In October 2020 Ugandan and Tanzanian researchers with ÐÇ¿Õ´«Ã½ and University Hospitals Cleveland Medical Center secured $5 million in funding from the National Institutes of Health/National Cancer Institute to establish an HIV-associated Malignancy Research Center (HAMRC) focused on lung cancer in East Africa.
This U.S and low- and middle-income Specialized Center Cooperative Agreement (U54) will investigate novel approaches to characterize lung cancer epidemiology, somatic mutation burden, HIV and accelerated aging, and use artificial intelligence to study lung cancer and the relationship to HIV-1 infection using radiological scans. At the forefront of this center include the establishment of national lung cancer diagnostic referral networks in Uganda and Tanzania, teleradiology, telepathology, technology transference, and training of early-career investigators and personnel.
Partner Institutions
United States
-
ÐÇ¿Õ´«Ã½
-
University Hospitals Cleveland Medical Center
Uganda
-
Joint Clinical Research Centre
-
Makerere University Lung Institute
-
Uganda Cancer Institute
-
Mulago National Hospital
Tanzania
-
National Institute for Medical Research
-
Muhumbili National Hospital
-
Ocean Road Cancer Institute
Principal Investigators
, U54 Multi-Principal Investigator
ÐÇ¿Õ´«Ã½/University Hospitals Cleveland Medical Center
Stanton L. Gerson, MD, U54 Multi-Principal Investigator
ÐÇ¿Õ´«Ã½
, U54 Multi-Principal Investigator
Makerere University Lung Institute
Sayoki Mfinanga, MD, PhD, U54 Multi-Principal Investigator
National Institute for Medical Research, Muhimbili Centre